At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
ASBP Aspire Biopharma Holdings Inc.
Pre-Mkt 03-23 06:02:10 EDT
0.7181
+0.0606
+9.22%
盘前0.6815
-0.0366-5.10%
04:47 EDT
High0.8120Low0.6869Vol268.04K
Open0.7038D1 Closing0.6575Amplitude19.03%
Mkt Cap3.61MTradable Cap2.20MTotal Shares5.02M
T/O196.13KT/O Rate8.74%Tradable Shares3.07M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Aspire Biopharma unit Buzz Bomb Caffeine signs national retail distribution deal with TruLife
Reuters  ·  03-19
Aspire Biopharma unit Buzz Bomb Caffeine signs national retail distribution deal with TruLife
Buzz Bomb Caffeine Company names John Choe Western Sales Director
Reuters  ·  03-17
Buzz Bomb Caffeine Company names John Choe Western Sales Director
Aspire Biopharma Subsidiary Buzz Bomb Caffeine Company Showcases BUZZ BOMB at HFA Show 2026
Reuters  ·  03-12
Aspire Biopharma Subsidiary Buzz Bomb Caffeine Company Showcases BUZZ BOMB at HFA Show 2026
Aspire Biopharma launches BUZZ BOMB Covenience Store Pack
TIPRANKS  ·  03-10
Aspire Biopharma launches BUZZ BOMB Covenience Store Pack
Aspire Biopharma Partners With Microsize on Sublingual Alprazolam Powder Development
Reuters  ·  03-03
Aspire Biopharma Partners With Microsize on Sublingual Alprazolam Powder Development
Aspire Biopharma Subsidiary Buzz Bomb Caffeine Company Posts Record Social Media Growth and Sales Surge
Reuters  ·  02-25
Aspire Biopharma Subsidiary Buzz Bomb Caffeine Company Posts Record Social Media Growth and Sales Surge
Aspire Biopharma Regains Nasdaq Listing Compliance
Reuters  ·  02-20
Aspire Biopharma Regains Nasdaq Listing Compliance
Aspire Biopharma Holdings Inc. Makes Investor Presentation Available
Reuters  ·  02-19
Aspire Biopharma Holdings Inc. Makes Investor Presentation Available
Aspire Subsidiary Buzz Bomb Caffeine Names ChicExecs PR Agency of Record
Reuters  ·  02-19
Aspire Subsidiary Buzz Bomb Caffeine Names ChicExecs PR Agency of Record
BRIEF-Aspire Biopharma Says Resale Of Up To 159.1 Mln Shares Of Common Stock Underlying Series A Convertible Preferred Stock
Reuters  ·  02-18
BRIEF-Aspire Biopharma Says Resale Of Up To 159.1 Mln Shares Of Common Stock Underlying Series A Convertible Preferred Stock
Aspire Biopharma Holdings Inc: Resale of up to 159,090,906 Shares of Common Stock Underlying Series a Convertible Preferred Stock
THOMSON REUTERS  ·  02-18
Aspire Biopharma Holdings Inc: Resale of up to 159,090,906 Shares of Common Stock Underlying Series a Convertible Preferred Stock
Aspire Biopharma Appoints Phillip Balatsos to Board of Directors
Reuters  ·  02-13
Aspire Biopharma Appoints Phillip Balatsos to Board of Directors
Aspire Biopharma files patent application for sublingual ondansetron formulation
TIPRANKS  ·  02-12
Aspire Biopharma files patent application for sublingual ondansetron formulation
Aspire Biopharma Raises $21 Million in Private Placement
Reuters  ·  02-11
Aspire Biopharma Raises $21 Million in Private Placement
Aspire Biopharma Amends Bylaws to Designate Series A Preferred Stock
Reuters  ·  02-07
Aspire Biopharma Amends Bylaws to Designate Series A Preferred Stock
Buzz Bomb Caffeine Company Showcases Sublingual Supplement at Sports Nutrition Summit
Reuters  ·  02-05
Buzz Bomb Caffeine Company Showcases Sublingual Supplement at Sports Nutrition Summit
Aspire Biopharma Subsidiary Buzz Bomb Signs Distribution Agreement with Blue Shark Beverages
Reuters  ·  02-03
Aspire Biopharma Subsidiary Buzz Bomb Signs Distribution Agreement with Blue Shark Beverages
Aspire Biopharma Holdings Announces Private Placement of Shares
Reuters  ·  01-31
Aspire Biopharma Holdings Announces Private Placement of Shares
Aspire Biopharma Signs Development Agreement with Microsize for Sublingual Aspirin
Reuters  ·  01-29
Aspire Biopharma Signs Development Agreement with Microsize for Sublingual Aspirin
Aspire Biopharma files patent application for sublingual alprazolam formulation
TIPRANKS  ·  01-20
Aspire Biopharma files patent application for sublingual alprazolam formulation

Introduction

Company Name.
Aspire Biopharma Holdings Inc.
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
PowerUp Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on video gaming, gaming adjacent, and metaverse businesses. PowerUp Acquisition Corp. was incorporated in 2021 and is based in New York, New York.
Issue price:
--